|
|
We invite you to join us in funding the PANDA Children’s Cancer Immunology Program that is on the cutting-edge of offering a promising option to fight cancer. Children fighting cancer face tremendous odds. Despite advances in survival rates, chemotherapy and radiation are toxic, causing short-term suffering and long-term complications.
The PANDA Children’s Cancer Immunology Program will fund research for a new option of treatment—immunotherapy. Immunotherapy re-programs a child’s own disease-fighting cells to recognize his or her own individual cancer cells and prevent them from multiplying. Scientists believe that a child’s own immune system may become an effective way to treat cancer or to prevent relapses.
Dr. Emmanuel Katsanis at the Steele Children’s Research Center heads a
team of physician-scientists conducting research in pediatric
immunotherapy. Dr. Katsanis and the Steele Center are one of the
few research centers in the country conducting pediatric cancer
immunology research and developing novel immunotherapy
treatments against cancer.
The PANDA
Children’s Cancer Immunology Program will fund the:
• Development of promising,
individualized anti-cancer vaccines to stimulate the immune
system to fight cancer
• Advancement of cancer
research—transitioning successful laboratory research to human
clinical trials
• Recruitment of scientists to the
Steele Center to further the expansion of pediatric cancer
immunology research
With your generous support, the PANDA Children’s Cancer Immunology Program can potentially change the way we treat pediatric cancer in the future!